QA1.792 — Li Fraumeni syndrome
Is QA1.792 billable?
Yes — QA1.792 is billable for FY2027. QA1.792 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. QA1.792 may be submitted for encounters from October 1, 2026 through September 30, 2027. QA1.792 is new in FY2027.
QA1.792 at a glance
| Code | QA1.792 |
|---|---|
| Description | Li Fraumeni syndrome |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
| FY2027 change | New in FY2027 |
Which MS-DRGs does QA1.792 group to?
QA1.792 sits in MDC 23 and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 951Other Factors Influencing Health Statusmedical
How is QA1.792 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to QA1.792. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Syndrome › Li-Fraumeni
Excludes2 — not included here — inherited from Chapter 17
The conditions below are not part of QA1.792, but a patient may have both at the same time. When documentation supports it, QA1.792 and the excluded code may both be reported.
- inborn errors of metabolism (E70-E88)
Excludes2 — not included here — inherited from QA1
The conditions below are not part of QA1.792, but a patient may have both at the same time. When documentation supports it, QA1.792 and the excluded code may both be reported.
- multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Code also — inherited from QA1
Two codes may be needed to describe the condition fully. Whether QA1.792 is sequenced first depends on the reason for the encounter.